MALVERN, Pa., May 08, 2018 -- Liberty Property Trust (NYSE:LPT), today announced that it has sold Five Crescent Drive, a 207,779 square foot office building at the Philadelphia Navy Yard for $130.5 million. The LEED® Platinum property is currently leased to GSK. The property was purchased by an affiliate of Korea Investment Management Co., Ltd (KIM) as advised by Coretrust Capital Partners, LLC.
“Five Crescent Drive is representative of the forward-looking work environment of the Philadelphia Navy Yard, which is the most successful redevelopment of a former Navy Yard in the nation," said John Gattuso, senior vice president and regional director for Liberty. "It has emerged as a vibrant business hub attracting talent from around the nation and investment from around the globe."
In connection with its joint venture partner, Synterra Partners, Liberty has developed 1.6 million square feet of high-performance office and industrial property at the Navy Yard. Currently under development is 1050 Constitution Avenue for Axalta Coatings Systems.
Liberty was represented by CBRE Capital Markets in the transaction.
About Liberty Property Trust
Liberty Property Trust (NYSE:LPT) is a leader in commercial real estate, serving customers in the United States and United Kingdom, through the development, acquisition, ownership and management of superior industrial and office properties. Liberty's 101 million square foot operating portfolio provides productive work environments for 1,200 tenants.
Inquiries:
Jeanne Leonard
Liberty Property Trust
610.648.1704


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



